Results 151 to 160 of about 364,439 (227)

A Comparative Prospective Study to Assess Efficacy of Intralesional MMR (Measles, Mumps, Rubella) Vaccine and Intralesional Vitamin D3 in Treatment of Nongenital Warts. [PDF]

Health Sci Rep
Baaniya B, Marahatta S, Dahal R, Shah N.
europepmc   +1 more source

Intralesional Measles, Mumps and Rubella Vaccine versus Formic Acid Puncture in the Treatment of Common Warts: A Prospective Randomised Study.

Indian J Dermatol, 2023
D'Souza MJ, Hundi GK, Dandekeri S, Jayaraman J.   +3 more
europepmc   +1 more source

Intralesional Immunotherapy with Measles-Mumps-Rubella Vaccine for Recalcitrant Facial Warts: A Report of Two Cases. [PDF]

Oman Med J, 2022
Al-Qassabi AM, Al Kindi A.
europepmc   +1 more source

The Oncogenic Human Papillomavirus Involvement as a Risk Factor of Measles, Mumps, and Rubella Vaccine Immunotherapy Failure in Anogenital Warts. [PDF]

Int Med Case Rep J
Achdiat PA, Ismiranty D, Hindritiani R, Rizqandaru T, Usman HA, Maharani RH.   +5 more
europepmc   +1 more source

A Comparative Analysis of Efficacy of Intralesional Mumps-Measles-Rubella Vaccine Versus 5-Fluorouracil in the Treatment of Palmoplantar Warts. [PDF]

Indian Dermatol Online J, 2022
Sunny AS, Doshi BR.
europepmc   +1 more source

Multiplexed VaxArray immunoassay for rapid antigen quantification in measles and rubella vaccine manufacturing. [PDF]

Vaccine X, 2021
Gillis JH, Thomas KN, Manoharan S, Panchakshari M, Taylor AW, Miller DF, Byrne-Nash RT, Riley C, Rowlen KL, Dawson E.   +9 more
europepmc   +1 more source

Immunogenicity and safety of measles-mumps-rubella vaccine delivered by the aerosol, intradermal and intramuscular routes in previously vaccinated young adults: a randomized controlled trial protocol. [PDF]

PLoS One
Saha S, Millier M, Samaranayaka A, Edmonds L, Best E, Ussher J, Anglemyer A, Lee J, Tatley M, Cutts F, van Binnendijk R, McIntyre P.   +11 more
europepmc   +1 more source

Safety and immunogenicity of Biological E's typhoid conjugate vaccine TYPHIBEV^Ⓡ concomitantly administered with measles rubella vaccine: a phase IV prospective, multicenter study. [PDF]

IJID Reg
Thuluva S, Matur RV, Gunneri S, Mogulla R, Dhar C, Yerroju V, Balne N, Chakravarthy BS, Narang M, Mahantshetti NS, Pandey AK.   +10 more
europepmc   +1 more source

Measles, mumps, and rubella vaccine at age 6 months and hospitalisation for infection before age 12 months: randomised controlled trial.

BMJ, 2023
Zimakoff AC, Jensen A, Vittrup DM, Herlufsen EH, Sørensen JK, Malon M, Svensson J, Stensballe LG.   +7 more
europepmc   +1 more source

TikTok content on measles-rubella vaccine in Jordan: A cross-sectional study highlighting the spread of vaccine misinformation. [PDF]

Narra J
Abdaljaleel M, Barakat M, Mahafzah A, Hallit R, Hallit S, Sallam M.   +5 more
europepmc   +1 more source